IMMUNOGEN, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

ITEM 2.02 - RESULTS OF OPERATION AND FINANCIAL CONDITION

On July 30, 2021, ImmunoGen, Inc. (Nasdaq: IMGN) issued a press release to announce the company's financial results for the quarter and six months ended June 30, 2021. The press release announcing financial results for the quarter and six months ended June 30, 2021 is included as Exhibit 99.1 and incorporated herein by reference.

ITEM 9.01 Financial Statements and Exhibits.

(d): Exhibits



Exhibit No.     Exhibit

    99.1          Press Release of ImmunoGen, Inc. dated July 30, 2021

    104         Cover Page Interactive Data File (embedded within the Inline XBRL
                (eXtensible Business Reporting Language) document).

© Edgar Online, source Glimpses